Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The current landscape of early drug development for patients with sarcoma in the immunotherapy era.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The current landscape of early drug development for patients with sarcoma in the immunotherapy era.
The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Future Oncol. 2018 May; 14(12):1197-1211.
View in:
PubMed
subject areas
Antineoplastic Agents, Immunological
Cancer Vaccines
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Costimulatory and Inhibitory T-Cell Receptors
Humans
Immunotherapy
Oncolytic Virotherapy
Oncolytic Viruses
Sarcoma
T-Lymphocytes
Treatment Outcome
authors with profiles
Robin Jones